Human papillomavirus testing in cervical cancer screening at a public health service of santiago, Chile;Examen de detección de virus papiloma humano en el tamizaje de cancer cervicouterino en un Servicio de Salud de Santiago, Chile

Revista Medica de Chile

Volumn 143, Issue 1, 2015, Pages 56-62

  Terrazas, Solana ^a   Ibáñez, Carolina ^a   Lagos, Marcela ^b   Poggi, Helena ^b   Brañes, Jorge ^b   Barriga, María Isabel ^b   Cartagena, Jaime ^b   Núñez, Felipe ^b   González, Francisca ^a   Cook, Paz ^a   Van De Wyngard, Vanessa ^a   Ferreccio, Catterina ^a,c  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c NONE   (Chile)

Author keywords

Chile; DNA probes, HPV; Papanicolaou test; Uterine cervical neoplasms

Indexed keywords

VIRUS DNA;

ADULT; ALPHAPAPILLOMAVIRUS; CHILE; EARLY DIAGNOSIS; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MASS SCREENING; MIDDLE AGED; PAPANICOLAOU TEST; PROCEDURES; PUBLIC HEALTH; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR; VIROLOGY;

ADULT; ALPHAPAPILLOMAVIRUS; CHILE; DNA, VIRAL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPANICOLAOU TEST; PUBLIC HEALTH; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84926169929     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: 10.4067/s0034-98872015000100007     Document Type: Article

References (19)

1. International Agency for Research on Cancer (IARC). Monographs on the evaluation of carcinogenic risks to humans. Human Papillomaviruses. Lyon, France: IARC; 2007.
2. Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, et al. HPV Screening for Cervical Cancer in Rural India. N Engl J Med 2009; 360 (14): 1385-94.
3. Ferreccio C, Barriga MI, Lagos M, Ibáñez C, Poggi H, González F, et al. Screening trial of human papillomavirus for early detection of cervical cancer in Santiago, Chile. Int J Cancer 2013; 132 (4): 916-23.
4. Sankaranarayanan R, Wesley RS. A Practical Manual on Visual Screening for Cervical Neoplasia. IARC Technical Publication N° 41 ed. Lyon, France: IARC Press; 2003.
5. Lorincz AT. Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening. J Obstet Gynaecol Res 1996; 22 (6): 629-36.
6. Almonte M, Murillo R, Sánchez GI, Jerónimo J, Salmeron J, Ferreccio C, et al. New paradigms and challenges in cervical cancer prevention and control in Latin America. Salud Publica Mex 2010; 52 (6): 544-59.
7. Herrero R, Ferreccio C, Salmeron J, Almonte M, Sánchez GI, Lazcano-Ponce E, et al. New approaches to cervical cancer screening in Latin America and the Caribbean. Vaccine 2008; 26 Suppl 11: L49-58.
8. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006; 119 (5): 1095-101.
9. Ministerio de Salud, Gobierno de Chile. Estadísticas Programa Cáncer cervicouterino, Informe 2011 de 27/29 Servicios de Salud. 2013; Available at: http://www.redcronicas.cl/index.php?option=com_docman&Itemid=301/. Consultado el 5 de octubre de 2013.
10. Stein MD, Fregnani JH, Scapulatempo C, Mafra A, Campacci N, Longatto-Filho A, et al. Performance and Reproducibility of Gynecologic Cytology Interpretation Using the Focal Point System: Results of the RODEO Study Team. Am J Clin Pathol 2013; 140 (4): 567-71.
11. Lewis M. A situational analysis of cervical cancer in Latin America and the Caribbean. Washington, D.C.: PAHO Library Catalog; 2004.
12. Safaeian M, Sherman ME. From papanicolaou to papillomaviruses: evolving challenges in cervical cancer screening in the era of human papillomavirus vaccination. J Natl Cancer Inst 2013; 105 (20): 1524-6.
13. Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Mayrand MH, Ronco G, et al. Overview of human papillomavirus- based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008; 26 (suppl 10): K29-K41.
14. Moyer VA, U.S. Preventive Services Task Force. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 156 (12): 880-91, W312.
15. Ministerio de Salud. Departamento de Estadísticas e Información de Salud. Cobertura (%) Pap vigente en mujeres beneficiarias de 25-64 años. 2013; Available at: http://www.deis.cl/cobertura/. Consultado el 24 de septiembre de 2013.
16. Tota JE, Ramana-Kumar AV, El-Khatib Z, Franco EL. The road ahead for cervical cancer prevention and control. Curr Oncol 2014; 21 (2): e255-64.
17. Maissi E, Marteau TM, Hankins M, Moss S, Legood R, Gray A. Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study. BMJ 2004; 328 (7451): 1293.
18. McCaffery K, Waller J, Nazroo J, Wardle J. Social and psychological impact of HPV testing in cervical screening: a qualitative study. Sex Transm Infect 2006; 82 (2): 169-74.
19. Papa D, Moore Simas TA, Reynolds M, Melnitsky H. Assessing the role of education in women’s knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening. J Low Genit Tract Dis 2009; 13 (2): 66-71.